Cargando…

Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex

[Image: see text] Oxacillinases (OXAs) β-lactamases are of special interest because of their capacity to hydrolyze antibacterial drugs such as cephalosporins and carbapenems, which are frequently used as the last option for the treatment of multidrug-resistant bacteria. Although the comprehension of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lizana, Ignacio, Ortiz-López, Diego, Delgado-Hurtado, Aleksei, Delgado, Eduardo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933777/
https://www.ncbi.nlm.nih.gov/pubmed/31891074
http://dx.doi.org/10.1021/acsomega.9b03022
_version_ 1783483277486587904
author Lizana, Ignacio
Ortiz-López, Diego
Delgado-Hurtado, Aleksei
Delgado, Eduardo J.
author_facet Lizana, Ignacio
Ortiz-López, Diego
Delgado-Hurtado, Aleksei
Delgado, Eduardo J.
author_sort Lizana, Ignacio
collection PubMed
description [Image: see text] Oxacillinases (OXAs) β-lactamases are of special interest because of their capacity to hydrolyze antibacterial drugs such as cephalosporins and carbapenems, which are frequently used as the last option for the treatment of multidrug-resistant bacteria. Although the comprehension of the involved mechanisms at the atomic level is crucial for the rational design of new inhibitors and antibiotics, currently there is no study on the acylation/deacylation mechanisms of the OXA-24/avibactam complex from first principles; therefore, mechanistic details such as activation barriers, characterization of intermediates, and transition states are still uncertain. In this article, we address the deacylation of the OXA-24/avibactam complex by molecular dynamics simulations and hybrid quantum mechanics/molecular mechanics computations. The study supplies mechanistic details not available so far, namely, topology of the potential energy surfaces, characterization of transition states and intermediates, and calculation of the respective activation barriers. The results show that the deacylation occurs via a mechanism of two stages; the first one involves the formation of a dianionic intermediate with a computed activation barrier of 24 kcal/mol. The second stage corresponds to the cleavage of the O(S81)–C bond promoted by the protonation of the O(S81) atom by the carboxylated Lys84 and the concomitant formation of the C(7)–N(6) bond, allowing the liberation of avibactam and recovery of the enzyme. The calculated activation barrier for the second stage is 13 kcal/mol. The structure of the intermediate, formed in the first stage, does not fulfill the characteristics of a tetrahedral intermediate. These results suggest that the recyclization of avibactam from the OXA-24/avibactam complex may occur without the emergence of tetrahedral intermediates, unlike that observed in the class A CTX-M-15.
format Online
Article
Text
id pubmed-6933777
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-69337772019-12-30 Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex Lizana, Ignacio Ortiz-López, Diego Delgado-Hurtado, Aleksei Delgado, Eduardo J. ACS Omega [Image: see text] Oxacillinases (OXAs) β-lactamases are of special interest because of their capacity to hydrolyze antibacterial drugs such as cephalosporins and carbapenems, which are frequently used as the last option for the treatment of multidrug-resistant bacteria. Although the comprehension of the involved mechanisms at the atomic level is crucial for the rational design of new inhibitors and antibiotics, currently there is no study on the acylation/deacylation mechanisms of the OXA-24/avibactam complex from first principles; therefore, mechanistic details such as activation barriers, characterization of intermediates, and transition states are still uncertain. In this article, we address the deacylation of the OXA-24/avibactam complex by molecular dynamics simulations and hybrid quantum mechanics/molecular mechanics computations. The study supplies mechanistic details not available so far, namely, topology of the potential energy surfaces, characterization of transition states and intermediates, and calculation of the respective activation barriers. The results show that the deacylation occurs via a mechanism of two stages; the first one involves the formation of a dianionic intermediate with a computed activation barrier of 24 kcal/mol. The second stage corresponds to the cleavage of the O(S81)–C bond promoted by the protonation of the O(S81) atom by the carboxylated Lys84 and the concomitant formation of the C(7)–N(6) bond, allowing the liberation of avibactam and recovery of the enzyme. The calculated activation barrier for the second stage is 13 kcal/mol. The structure of the intermediate, formed in the first stage, does not fulfill the characteristics of a tetrahedral intermediate. These results suggest that the recyclization of avibactam from the OXA-24/avibactam complex may occur without the emergence of tetrahedral intermediates, unlike that observed in the class A CTX-M-15. American Chemical Society 2019-12-12 /pmc/articles/PMC6933777/ /pubmed/31891074 http://dx.doi.org/10.1021/acsomega.9b03022 Text en Copyright © 2019 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Lizana, Ignacio
Ortiz-López, Diego
Delgado-Hurtado, Aleksei
Delgado, Eduardo J.
Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex
title Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex
title_full Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex
title_fullStr Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex
title_full_unstemmed Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex
title_short Theoretical Evidence for the Nonoccurrence of Tetrahedral Intermediates in the Deacylation Pathway of the Oxacillinase-24/Avibactam Complex
title_sort theoretical evidence for the nonoccurrence of tetrahedral intermediates in the deacylation pathway of the oxacillinase-24/avibactam complex
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933777/
https://www.ncbi.nlm.nih.gov/pubmed/31891074
http://dx.doi.org/10.1021/acsomega.9b03022
work_keys_str_mv AT lizanaignacio theoreticalevidenceforthenonoccurrenceoftetrahedralintermediatesinthedeacylationpathwayoftheoxacillinase24avibactamcomplex
AT ortizlopezdiego theoreticalevidenceforthenonoccurrenceoftetrahedralintermediatesinthedeacylationpathwayoftheoxacillinase24avibactamcomplex
AT delgadohurtadoaleksei theoreticalevidenceforthenonoccurrenceoftetrahedralintermediatesinthedeacylationpathwayoftheoxacillinase24avibactamcomplex
AT delgadoeduardoj theoreticalevidenceforthenonoccurrenceoftetrahedralintermediatesinthedeacylationpathwayoftheoxacillinase24avibactamcomplex